Stock comparison
BOSTON SCIENTIFIC CORP is 63.2x more valuable than TANDEM DIABETES CARE INC by market capitalization ($66.87 B vs $1.06 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
BSX is larger
BOSTON SCIENTIFIC CORP is 63.2x more valuable than TANDEM DIABETES CARE INC by market capitalization ($66.87 B vs $1.06 B).
Market value leader
BSX
BOSTON SCIENTIFIC CORP is 63.2x more valuable than TANDEM DIABETES CARE INC by market capitalization ($66.87 B vs $1.06 B).
Revenue leader
BSX
TNDM: $1.01B vs BSX: $20.07B.
| Metric | TNDM | BSX |
|---|---|---|
| Market cap | $1.06 B | $66.87 B |
| US-listed rank | #2600 | #256 |
| Revenue (latest FY) | $1.01B | $20.07B |
| Net income (latest FY) | -$204.70M | - |
| Net margin | -20.2% | - |
| P/E (trailing FY) | - | - |
| SEC filings | 1,234 | 1,009 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
BOSTON SCIENTIFIC CORP is 63.2x more valuable than TANDEM DIABETES CARE INC by market capitalization ($66.87 B vs $1.06 B).
In their latest fiscal years, TANDEM DIABETES CARE INC reported $1.01B in revenue while BOSTON SCIENTIFIC CORP reported $20.07B.
Full pages: TANDEM DIABETES CARE INC and BOSTON SCIENTIFIC CORP, or browse the full rankings.